Should you build or buy Life Sciences CRM?
Life sciences CRM software runs pharma and medtech sales operations: rep call reporting, sample accountability under PDMA rules, HCP engagement tracking, and Sunshine Act spend disclosure, all inside a validated environment. It is built for regulated commercial teams, not general sales, and every action has to survive an FDA or state audit.
Buy. The regulated core (PDMA sample controls, Part 11 validation, transparency reporting) is what you pay Veeva, Salesforce or IQVIA for, and no manufacturer has replaced it in production. Put the engineering into the data, content and targeting layers around the CRM instead.
Build it, buy it, or bridge?
When building makes sense
There is little build case here, and the evidence backs that up directly. No pharma, biotech, or medtech company is documented running a self-built CRM that covers rep call reporting, PDMA sample compliance, HCP engagement, and Sunshine Act spend disclosure together. Manufacturers have customized general CRM platforms like Salesforce and HubSpot for narrower sales-territory or account-management workflows, but no such case is documented in enough detail to show it touches the sample-accountability or MLR content-review workflows that make this category regulated in the first place. What can reasonably be built is the layer above the CRM: territory design logic, HCP segmentation models, and commercial analytics tuned to a company's own strategy. The validated core itself, sample accountability under PDMA, Sunshine Act capture, and Part 11 audit trails, is regulatory plumbing that a self-build has to reproduce exactly, not improve on, which removes most of the reason to build it.
When buying makes sense
Buying is the clear call. Veeva Vault CRM reports more than 190 customers live, each running pre-validated compliance controls that a self-build would have to reproduce from scratch with no margin for error. Salesforce Life Sciences Cloud documents the same sample-inventory and license-validation workflows for companies that prefer that platform. The paid capability is the capability field teams actually use every day, which is the strongest sign a category's core is worth buying rather than building. The one real decision left is which vendor to be on: Veeva ended its platform agreement with Salesforce, setting a firm 2030 end-of-support date for Veeva CRM running on Salesforce infrastructure, which forces every current Veeva CRM customer into a migration decision regardless of whether they build anything else. The technical migration is rarely the hard part; global template redesign and field-force retraining across dozens of affiliates is what actually takes 18 to 36 months.
The desk read
Build-versus-buy analysis for Life Sciences CRM is being written. In the meantime, the framework that drives every B4 call is on the B4 Index page.
Frequently asked
What is life sciences CRM software?
Everything else about it looks like ordinary sales software: territory maps, call logs, opportunity pipelines. The difference shows up after a rep leaves an office. A validated CRM logs that visit in a form an FDA or state auditor can trust years later, which turns out to be a harder engineering problem than it sounds.
Can a pharma company build its own CRM?
Not the regulated core. No manufacturer is documented running a self-built system that covers sample accountability, Sunshine Act capture, and Part 11 validation together. Some companies have customized general CRM platforms for sales-territory or account-management workflows, but not the compliance layer, and no such case is documented with enough detail to verify.
Why is the Veeva-Salesforce split forcing a decision now?
Veeva ended its platform agreement with Salesforce and set a firm end-of-support date for Veeva CRM running on Salesforce infrastructure. Global template redesign and retraining thousands of field reps across dozens of affiliates typically take 18 to 36 months, so waiting until close to the deadline to start planning is the real risk.
What are the main life sciences CRM vendors?
Representative vendors include AiDEA Sales, Close-Up CRM, Veeva CRM, Salesforce Life Sciences Cloud, IQVIA Orchestrated Customer Engagement, TikaMobile. Veeva, Salesforce sit at the center of the coming platform split, each pre-validated for PDMA, Sunshine Act, Part 11 compliance. IQVIA's OCE targets similar ground for companies already using its data, analytics suite. AiDEA Sales, Close-Up CRM serve smaller manufacturers on Dynamics 365, standalone platforms. B4 Pro includes the category score and the full vendor list.